arcadia

PIRAMAL ENTERPRISES LTD.

NSE : PELBSE : 500302ISIN CODE : INE140A01024Industry : Pharmaceuticals & DrugsHouse : Piramal Ajay
BSE1781.4055.8 (+3.23 %)
PREV CLOSE ( ) 1725.60
OPEN PRICE ( ) 1715.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1781.40 (4)
VOLUME 47460
TODAY'S LOW / HIGH ( )1699.55 1790.80
52 WK LOW / HIGH ( )1651.8 3302.55
NSE1779.9555.45 (+3.22 %)
PREV CLOSE( ) 1724.50
OPEN PRICE ( ) 1720.00
BID PRICE (QTY) 1779.95 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 870022
TODAY'S LOW / HIGH( ) 1700.00 1790.00
52 WK LOW / HIGH ( )1652.35 3307.95
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 26-04 1947
Management Info
Ajay G Piramal - Chairman - Managing Director
Registered Office

Address Piramal Ananta Agastya Corporate Park ,Opposite Fire Brigade , Kamani Junction , L B S Marg ,Kurla ( W ),
Mumbai,
Maharashtra-400070

Phone 022 3802 3000/4000

Email complianceofficer.phl@piramal.com

Website www.piramal.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
23Aug Piramal Enterprises informs about loss
Piramal Enterprises has informed about loss of share certificate / issue..
30Jul Piramal Enterprises turns black in Q1
Piramal Enterprises has reported results for first quarter ended June 30..
17Jul Piramal Enterprises trades in green on
Piramal Enterprises is currently trading at Rs. 2060.00, up by 23.20 poi..
16Jul CRISIL reaffirms highest rating for CP
CRISIL has reaffirmed the highest rating, ‘A1+’ to Piramal Enterprises’..
12Jul Piramal Enterprises planning to shift
Piramal Enterprises is planning to shift its borrowing mix to longer-ter..
Financials
Rs. in Millions
QTR Jun 19 ANNUAL 19
Net Profit-388.4-8619.8
Gross Profit -981.2 -7915.8
Operating Profit 4292.121241.7
Net Sales 8719.836714
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Sanofi India (BSE)
 6032.65 (1.46%)
M.Cap ( in Cr)13893.57
Astrazeneca Pharma I (BSE)
 1746.40 (4.12%)
M.Cap ( in Cr)4366.00
Abbott India (BSE)
 8786.90 (0.61%)
M.Cap ( in Cr)18671.55
Alkem Laboratories (BSE)
 1771.30 (1.21%)
M.Cap ( in Cr)21178.55
Pfizer (BSE)
 2901.05 (0.72%)
M.Cap ( in Cr)13271.65
Shareholding Pattern
PROMOTERS 46.1%
NON-INSTITUTION 16.27%
FI/BANKS/INSURANCE 8%
MUTUAL FUNDS/UTI 0.47%
GOVERNMENT 0%
FII 0%
Attention Investors

"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."

"Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number and Email address with your Depository Participant. Receive alerts on your Registered Mobile and Email address for all debit and other important transactions in your demat account directly from CDSL on the same day..... issued in the interest of investors."

"No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

ARCADIA SHARE & STOCK BROKERS PVT. LTD.

MEMBER NSE (CASH & DERIVATIVES) : INB/F_230778238

MEMBER BSE (CASH) : INB010778232

MEMBER CDSL DP : IN225

ARCADIA COMMODITIES & TRADING

MEMBER MCX : 10950

MEMBER NCDEX : 00374 & FMC – MCX/TCM/PART/0503 & FMC –NCDEX/TCM/PART/0356 & ACE COMMODITY EXCHANGE MEMBER ID –

6090 FMC – ACE/TCM/PART/0252 & NSEL MEMBER - 14120 SEBI- NCDEX - INZ000048620

Copyright © 2017 Arcadia Share & Stock Brokers Pvt. Ltd.

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

GO TO TOP
CLOSE X
Exclusive Email address for the Customer Grievance dphelp@arcadiashare.com
CLOSE

COMPLAINTS FORM